| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
389,580,000 |
| Market
Cap: |
48.93(B) |
| Last
Volume: |
1,986,875 |
Avg
Vol: |
1,913,313 |
| 52
Week Range: |
$75.49 - $140.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 487 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
213,540 |
279,977 |
302,946 |
572,908 |
| Total Sell Value |
$28,796,122 |
$36,914,107 |
$39,522,516 |
$69,867,568 |
| Total People Sold |
7 |
10 |
14 |
15 |
| Total Sell Transactions |
14 |
27 |
46 |
80 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leach Jacob Steven |
EVP Chief Technology Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$7 |
D/D |
6,741 |
79,019 |
|
- |
|
| Flynn Paul R |
EVP Global Revenue |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,297 |
19,150 |
|
- |
|
| Shrishrimal Sumi |
SVP Chief Risk Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$3 |
D/D |
2,889 |
15,146 |
|
- |
|
| Stern Sadie |
EVP Chief Human Resources Off |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,297 |
18,758 |
|
- |
|
| Dolan Matthew Vincent |
SVP Corporate Development |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$3 |
D/D |
2,889 |
10,435 |
|
- |
|
| Selvaraj Shelly Ramasamy |
SVP Chief Information Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$3 |
D/D |
2,889 |
15,685 |
|
- |
|
| Sayer Kevin R |
Chairman, CEO & President |
• • – |
2022-03-08 |
4 |
A |
$0.00 |
$16 |
D/D |
16,251 |
110,868 |
|
- |
|
| Patterson Chad |
EVP, Global Marketing |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,297 |
17,825 |
|
- |
|
| Regan Barry J. |
EVP Global Operations |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
4,984 |
18,112 |
|
- |
|
| Abbey Donald |
EVP Quality Regulatory Affairs |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
4,984 |
53,658 |
|
- |
|
| Pacelli Steven Robert |
Managing Dir., Dexcom Ventures |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
4,984 |
39,354 |
|
- |
|
| Brown Micheal Jon |
EVP Chief Legal Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$12 |
D/D |
12,038 |
12,038 |
|
- |
|
| Sylvain Jereme M |
EVP, Chief Financial Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,297 |
19,959 |
|
- |
|
| Balo Andrew K |
EVP, Global Medical Affairs |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
4,984 |
19,045 |
|
- |
|
| Dolan Matthew Vincent |
*Officer |
• – – |
2022-03-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,546 |
|
-82% |
|
| Sylvain Jereme M |
EVP, Chief Financial Officer |
• – – |
2022-03-04 |
4 |
AS |
$422.94 |
$253,764 |
D/D |
(600) |
14,662 |
|
-82% |
|
| Patterson Chad |
EVP, Global Marketing |
• – – |
2022-03-01 |
4 |
AS |
$413.97 |
$19,043 |
D/D |
(46) |
12,528 |
|
-81% |
|
| Pacelli Steven Robert |
Managing Dir., Dexcom Ventures |
• – – |
2022-02-23 |
4 |
AS |
$394.33 |
$98,583 |
D/D |
(250) |
34,370 |
|
-79% |
|
| Sayer Kevin R |
Chairman, CEO & President |
• • – |
2022-02-14 |
4 |
AS |
$418.04 |
$1,254,120 |
D/D |
(3,000) |
94,617 |
|
-81% |
|
| Kahn Barbara |
Director |
– • – |
2022-02-10 |
4 |
AS |
$428.55 |
$2,064,014 |
I/I |
(4,666) |
3,000 |
|
-84% |
|
| Pacelli Steven Robert |
Managing Dir., Dexcom Ventures |
• – – |
2022-01-24 |
4 |
AS |
$416.77 |
$104,193 |
D/D |
(250) |
34,620 |
|
-27% |
|
| Sayer Kevin R |
Chairman, CEO & President |
• • – |
2022-01-18 |
4 |
AS |
$435.06 |
$9,875,800 |
D/D |
(22,674) |
97,617 |
|
-35% |
|
| Sayer Kevin R |
Chairman, CEO & President |
• • – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
38,586 |
117,291 |
|
- |
|
| Pacelli Steven Robert |
Managing Dir., Dexcom Ventures |
• – – |
2021-12-23 |
4 |
AS |
$573.91 |
$143,478 |
D/D |
(250) |
34,870 |
|
-29% |
|
| Stern Sadie |
EVP Chief Human Resources Off |
• – – |
2021-12-15 |
4 |
A |
$0.00 |
$2 |
D/D |
1,671 |
13,461 |
|
- |
|
2293 Records found
|
|
Page 10 of 92 |
|
|
4.93 (3.78%) 
